Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Wells Fargo trades near $79 as investors priced in about 16% upside over the next year, driven by regulatory relief, ...
Shimmick's Q1 2026 results offer a window into infrastructure demand and cost pressures. This article breaks down the...
DHL Supply Chain’s push to automation has rolled out 8,000 robots changing work across its global network, delivering...
A looming energy squeeze could pressure household budgets and corporate profits. This article breaks down what shorta...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
A sharp 60% drop in CBIZ shares has investors buzzing about risk and value. This guide breaks down why the stock move...
Petco's WOOF ticker hints at a pet retailer balancing stores, services, and digital growth. This investor guide break...
The US is accelerating domestic rare-earth initiatives, and investment banks keep raising targets on MP Materials. Th...
Apple is accelerating AI across its ecosystem. This article breaks down the two big profit engines, what it means for...
SpaceX opened at $160.95 per share and briefly topped a $2 trillion valuation on debut, then pulled back to more mode...
A major tech partnership and improving chip demand helped Intel stock climb sharply on Thursday. This deep dive expla...